相关实验视频

Updated: Jul 5, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

线粒体拓素酶1向抗癌疗法,使用化剂封装的介质型MIL-101 (Fe) 合成通过蒸汽辅助方法

Anirban Ghosh¹, Arijit Ghosh², Arpan Bhattacharyya²

¹School of Materials Sciences, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, Jadavpur, Kolkata 700 032, India. msab@iacs.res.in.

Dalton transactions (Cambridge, England : 2003)

|January 24, 2024

概括

研究人员开发了一种新的药物递送系统,使用MIL-101 () 纳米颗粒来准线粒体. 这种系统有效地提供伊利诺甲来捕获线粒体拓酶1共价复合体,显示出新的抗癌疗法的前景.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
癌症治疗方法癌症治疗方法

背景情况:

线粒体拓酶1 (Top1mt) 对于线粒体DNA (mtDNA) 的维护和细胞能量生产至关重要.
向线粒体提供了一种提高抗癌药物疗效和降低全身毒性的策略.

研究的目的:

设计和评估一种载体介导的药物输送系统,用于向线粒体输送 irinotekan.
为了研究由含有虹膜素的纳米粒子在线粒体内对Top1mt共价复合体 (Top1mtcc) 的选择性捕获.

主要方法:

使用蒸汽辅助溶热方法合成生物相容的半孔金属有机框架 (MOF) MIL-101 (Fe).
在MIL-101 (Fe) 中封装氨基酸以产生MIL-Iri纳米颗粒,用于定向的线粒体输送.
评估MIL-Iri在诱导Top1mtcc,导致mtDNA损伤和导致人类结肠和乳腺癌细胞细胞毒性的有效性.

主要成果:

选择性地在线粒体内定位的MIL-101 (Fe) 纳米粒子.
在低纳米分子度下,MIL-Iri证明了对Top1mtcc的剂量依赖的捕获.
在癌细胞中,MIL-Iri诱导了显著的mtDNA损伤和细胞毒性.

结论:

该MIL-101 ((Fe) 载体系统能够有效地将虹膜素向线粒体提供.
这一策略代表了通过利用线粒体Top1mt.利用抗癌化疗的一种新且有效的方法.
这些发现支持通过线粒体向治疗癌症开发新的治疗策略.

更多相关视频

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...